Abstract
Background
Research on penile cancer (PeCa) is predominantly conducted in countries with centralized treatment of PeCa-patients. In Germany and Austria (G + A), no state-regulated centralization is established, and no information is available on how PeCa-research is organized.
Methods
Current research competence in PeCa was assessed by a 36-item questionnaire sent to all chairholders of urological academic centers in G + A. Based on PubMed records, all scientific PeCa-articles of 2012–2022 from G + A were identified. Current research trends were assessed by dividing the literature search into two periods (P1: 2012–2017, P2: 2018–2022). A bibliometric analysis was supplemented.
Results
Response rate of the questionnaire was 75%, a median of 13 (IQR: 9–26) PeCa-patients/center was observed in 2021. Retrospective case series were conducted by 38.9% of participating clinics, while involvement in randomized-controlled trials was stated in 8.3% and in basic/fundamental research in 19.4%. 77.8% declared an interest in future multicenter projects. 205 PeCa-articles were identified [median impact factor: 2.77 (IQR: 0.90–4.37)]. Compared to P1, P2 showed a significant increase in the median annual publication count (29 (IQR: 13–17) vs. 15 (IQR: 19–29), p < 0.001), in multicenter studies (79.1% vs. 63.6%, p = 0.018), and in multinational studies (53% vs. 28.9%, p < 0.001); the proportion of basic/fundamental research articles significantly declined (16.5% vs. 28.9%, p = 0.041). Four of the top-5 institutions publishing PeCa-articles are academic centers. Bibliometric analyses revealed author networks, primary research areas in PeCa, and dominant journals for publications.
Conclusions
Given the lack of centralization in G + A, this analysis highlights the need for research coordination within multicenter PeCa-projects. The decline in basic/fundamental research should be effectively addressed by the allocation of funded research projects.
Similar content being viewed by others
Data availability
The data sets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. A Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Quhal F, Pradere B, Mori K, Shariat SF (2020) Volume outcome relationship in penile cancer: a systematic review. Curr Opin Urol 30(5):696–700. https://doi.org/10.1097/MOU.0000000000000803
Williams SB, Ray-Zack MD, Hudgins HK, Oldenburg J, Trinh QD, Nguyen PL, Shore ND, Wirth MP, O’Brien T, Catto JWF (2019) Impact of centralizing care for genitourinary malignancies to high-volume providers: a systematic review. Eur Urol Oncol 2(3):265–273. https://doi.org/10.1016/j.euo.2018.10.006
Lebentrau S, Wakileh GA, Schostak M, Schmid HP, Suarez-Ibarrola R, Merseburger AS, Hutterer GC, Necknig UH, Rink M, Bögemann M, Kluth LA, Pycha A, Burger M, Brookman-May SD, Bründl J, May M (2021) Does the identification of a minimum number of cases correlate with better adherence to international guidelines regarding the treatment of penile cancer? survey results of the European PROspective Penile Cancer Study (E-PROPS). Front Oncol 11:759362. https://doi.org/10.3389/fonc.2021.759362
Pallauf M, Hempel MC, Hupe MC, May M, Haccius M, Weckermann D, Lebentrau S, Hoschke B, Necknig U, Pfitzenmaier J, Manka L, Nuhn P, Törzsök P, Lusuardi L, Merseburger AS (2020) Adherence to the EAU guideline recommendations for local tumor treatment in penile cancer: results of the European PROspective Penile Cancer Study Group Survey (E-PROPS). Adv Ther 37(12):4969–4980. https://doi.org/10.1007/s12325-020-01514-8
Distler FA, Pahernik S, Gakis G, Hutterer G, Lebentrau S, Rink M, Nuhn P, Brookman-May S, Burger M, Gratzke C, Wolff I, May M (2020) Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey. World J Urol 38(10):2523–2530. https://doi.org/10.1007/s00345-019-03052-7
Mistretta FA, Cyr SJ, Palumbo C, Mazzone E, Knipper S, Tian Z, Nazzani S, Montanari E, Tilki D, Briganti A, Shariat SF, Perrotte P, Saad F, de Cobelli O, Karakiewicz PI (2020) Adherence to guideline recommendations for perioperative chemotherapy in patients with pN2–3 M0 squamous cell carcinoma of the penis: temporal trends and survival outcomes. Clin Oncol 32(4):e93–e101. https://doi.org/10.1016/j.clon.2019.10.001
Jakobsen JK, Pettaway CA, Ayres B (2021) Centralization and equitable care in rare urogenital malignancies: the case for penile cancer. Eur Urol Focus 7(5):924–928. https://doi.org/10.1016/j.euf.2021.09.019
Bandini M, Ahmed M, Basile G, Watkin N, Master V, Zhu Y, Prakash G, Rodriguez A, Ssebakumba MK, Leni R, Cirulli GO, Ayres B, Compitello R, Pederzoli F, Joshi PM, Kulkarni SB, Montorsi F, Sonpavde G, Necchi A, Spiess PE (2022) A global approach to improving penile cancer care. Nat Rev Urol 19(4):231–239. https://doi.org/10.1038/s41585-021-00557-y
May M, Lebentrau S, Ayres B, Albersen M, Protzel C, Chahoud J, Brouwer OR, Pettaway CA, Pagliaro LC, Necchi A, Watkin N, Hakenberg OW, Spiess PE et al (2023) The goal of achieving high-quality surgical first-line therapy in patients with penile cancer is important; however, some collective efforts are still required in order to reach it. Comment on Brassetti combined reporting of surgical quality and cancer control after surgical treatment for penile tumors with inguinal lymph node dissection: the tetrafecta achievement. Curr. Oncol. 30, 1882–1892. Curr Oncol (Toronto, Ont) 30(4):4269–4274. https://doi.org/10.3390/curroncol30040325
Wever L, de Vries HM, Dell’Oglio P, van der Poel HG, Donswijk ML, Sikorska K, van Leeuwen FWB, Horenblas S, Brouwer OR (2022) Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer. BJU Int 130(4):486–495. https://doi.org/10.1111/bju.15725
Ager M, Njoku K, Serra M, Robinson A, Pickering L, Afshar M, Vyas L, Eardley I, Kayes O, Elmamoun M, Khoo V, Ayres B, Henry A, Watkin N, Tree AC (2021) Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis. BJU Int 128(4):451–459. https://doi.org/10.1111/bju.15309
Lebentrau S, Yakac A, Lusuardi L, Thomas C, Sarcan S, Burger M, Merseburger AS, Wiegland J, Gilfrich C, Wolff I, May M (2023) Are there volume-related effects on treatment options for patients with penile cancer? Results of a survey of university hospitals in Germany and Austria. Aktuelle Urol (accepted). https://doi.org/10.1055/a-2090-5199
National Institute for Health and Care Excellence. Improving outcomes in urological cancers. Cancer service guideline CSG2. London, UK: NICE; 2002. www.nice.org.uk/guidance/csg2. Accessed 09 June 2023
Brouwer OR, Albersen M, Parnham A, Protzel C, Pettaway CA, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J, Fernández-Pello S, Greco I, van der Heijden MS, Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Tagawa ST (2023) European Association of Urology-American society of clinical oncology collaborative guideline on penile cancer: 2023 update. Eur Urol 83(6):548–560. https://doi.org/10.1016/j.eururo.2023.02.027
Deutsche Gesellschaft für Urologie e.V. (DGU), S3-Leitlinie Diagnostik, Therapie und Nachsorge des Peniskarzinoms, Version 1.0, August 2020, https://www.leitlinienprogrammonkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Peniskarzinom/Version_1/LL_Peniskarzinom_Langversion_1.0.pdf. Accessed 09 June 2023
https://www.auanet.org/myaua_login?returnurl=https%3A%2F%2Funiversity.auanet.org%2Fcore%2Foncology-adult%2Fpenile-neoplasms%2Findex.cfm%3F. Accessed 09 June 2023
Jeanne-Julien A, Bouchot O, De Vergie S, Branchereau J, Perrouin-Verbe MA, Rigaud J (2023) Long-term oncological results in penile cancer treated by inguinal lymphadenectomy. World J Urol 41(6):1589–1595. https://doi.org/10.1007/s00345-023-04390-3
Tappero S, Piccinelli M, Barletta F, Panunzio A, Cano Garcia C, Incesu RB, Tian Z, Parodi S, Dell’Oglio P, De Cobelli O, Briganti A, Antonelli A, Chun FKH, Graefen M, Saad F, Shariat SF, Suardi NR, Borghesi M, Terrone C, Karakiewicz PI (2023) Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis. World J Urol 41(1):119–125. https://doi.org/10.1007/s00345-022-04184-z
Jeanne-Julien A, Bouchot O, De Vergie S, Branchereau J, Perrouin-Verbe MA, Rigaud J (2023) Morbidity and risk factors for complications of inguinal lymph node dissection in penile cancer. World J Urol 41(1):109–118. https://doi.org/10.1007/s00345-022-04169-y
Deng S, Xuan Z, Feng J, Li H, Wang B, Yang Z, Xuan L, Meng F, Wang L, Xiao Y, Wang J (2023) Global research trends in penile cancer: Bibliometric and visualized analysis. Front Oncol 12:1091816. https://doi.org/10.3389/fonc.2022.1091816
Acknowledgements
The authors of this study would like to express their sincere gratitude to the urological chairholders of the academic centers in Germany and Austria who responded to our questionnaire, as it is only through their responses that this original work could have been created.
Funding
Matthias May certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None.
Author information
Authors and Affiliations
Contributions
Matthias May had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: May, Thomas, Lebentrau. Acquisition of data: May, Thomas, Lusuardi, Sarcan, Yakac, Wiegland. Analysis and interpretation of data: May, Sarcan, Wolff, Kravchuk, Lusuardi, Wiegland, Yakac, Thomas, Burger, Gilfrich, Lebentrau, Ahyai, Merseburger. Drafting of the manuscript: May, Sarcan, Wolff. Critical revision of the manuscript for important intellectual content: May, Sarcan, Wolff, Kravchuk, Lusuardi, Wiegland, Yakac, Thomas, Burger, Gilfrich, Lebentrau, Ahyai, Merseburger. Statistical analysis: May. Obtaining funding: None. Administrative, technical, or material support: None. Supervision: May, Thomas, Lusuardi, Burger, Ahyai, Merseburger. Other: None.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human participants
This study was approved by a positive vote from the Ethics Committee of the Technical University of Dresden (BO-EK-160042023), and we certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sarcan, S., Wolff, I., Lusuardi, L. et al. The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search. World J Urol 42, 12 (2024). https://doi.org/10.1007/s00345-023-04719-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00345-023-04719-y